Cite

HARVARD Citation

    Breitman, M. et al. (2022). Optimization of Human Mesenchymal Stem Cells for Rheumatoid Arthritis: Implications for Improved Therapeutic Outcomes. ACR open rheumatology. 4 (2), pp. 152-160. [Online]. 
  
Back to record